Market Overview

UPDATE: JP Morgan Upgrades Aetna to Overweight on Revised Numbers Post Deal Closure

Share:
Related AET
UPDATE: Credit Suisse Reiterates Outperform, Raises Price Target On Aetna Following Investor Meetings
Paulson & Company's Q4 Moves: Healthcare And Beyond
Cracking The Best Healthcare Dividend Stock Secrets (GuruFocus)

JP Morgan raised its rating on Aetna (NYSE: AET) from Neutral to Overweight and increased its price target from $46 to $52.

JP Morgan said, "We are upgrading Aetna to Overweight from Neutral and raising our price target from $46 to $52 on the expectation of upwardly revised numbers post CVH deal closing, AET's below-average reform exposure and most importantly an increasing recognition of the company's ACO positioning. From a catalyst perspective, at next Wednesday's investor day we expect initial 2013 EPS guidance in the $5.40 range (JPM $5.40, consensus $5.51), within the range of investor expectations."

Aetna closed at $43.43 on Thursday.

Latest Ratings for AET

DateFirmActionFromTo
Feb 2015Deutsche BankMaintainsBuy
Feb 2015Deutsche BankMaintainsBuy
Feb 2015UBSMaintainsBuy

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (AET)

Around the Web, We're Loving...

Get Benzinga's Newsletters